ISTH Congress Abstracts

Official abstracts site for the ISTH Congress

MENU 
  • Home
  • Congress Archive
    • ISTH 2022 Congress
    • ISTH 2021 Congress
    • ISTH 2020 Congress
  • Resources
  • Search

ISTH 2021 Congress

July 17-21, 2021. Philadelphia, PA.

View by Title View by Number View Themes
Jump to:  View All • a b c d e f g [h] i j k l m n o p q r s t u v w x y z
  • Abstract Number: PB0154

    Haematological, Coagulation and Biochemical Abnormalities in Covid-19 Patients in India: Do We Behave Differently?

    N. Awasthi1, V. Tiwari1, S. Naqvi1, P. Das1, S. Aswal1, N. Husain1, A. Tripathi1

  • Abstract Number: PB0620

    Haemophilia A Genotyping in Patients with Discrepancy in FVIII Activity Levels Measured with One-stage and Chromogenic Assays

    L. Rossetti1, V. Marchione1, M. Arias2, E. Sueldo2, C.P. Radic1, B. Ziegler1, M.M. Abelleyro1, K. Waisman1, A. Baqués3, C. De Brasi1,4

  • Abstract Number: OC 18.3

    Haemostatic Components Are Associated with Risk of Venous Thromboembolism after Lower Leg Trauma

    C. Touw1, B. Nemeth1, R. van Adrichem1, W. Lijfering1, A. van Hylckama Vlieg1, R. Nelissen1, T. Lisman2, S. Cannegieter1

  • Abstract Number: PB0289

    Haemostatic Dysfunctions in COVID-19 Infection: A Systematic Review

    S. Abegunde1, A. Adedeji2

  • Abstract Number: PB0286

    Head-to-Head Comparison of Cytokines Storm-induced Coagulopathy in Septic Shock and Covid-19

    J. De Poortere1, M. Dechamps1,2, P.-F. Laterre3, M. Octave1, A. Gigion1, V. Robaux1, L. Pirotton1, J. Bodart1, L. Gerard1,3, D. Gruson4, M.-A. van Dievoet4, J. Douxfils5, M. Derive6, L. Gatto7, C. Bouzin1, D. Castanares-Zapatero1,3, L. Bertrand1, S. Horman1, C. Beauloye1,8

  • Abstract Number: PB0572

    Health Care Resource Use (HRU) among Adult Persons with Hemophilia A (PwHA) and Concurrent Joint Disease (JD) in the United States

    L.E. Markson1, P.F. Fogarty1, L. Ban2, Y. Chen1, R. Zaha3, L. Young4

  • Abstract Number: PB0571

    Health Care Resource Use (HRU) among Adult Persons with Hemophilia B (PwHB) and Concurrent Joint Disease (JD) in the United States

    L.E. Markson1, L. Young2, L. Ban3, Y. Chen1, R. Zaha4, P.F. Fogarty1

  • Abstract Number: PB1288

    Heavy Menstrual Bleeding: Knowledge and Practice Assessment among Tunisian Primary Care Physicians

    E. Hammami1, I. Helali1

  • Abstract Number: PB0283

    Hematologic Abnormalities in Moderate Forms of Covid-19

    M. Ben Ayed1, M. Chelli1, H. Baccouche1, S. Saffar1, A. Chakroun1, S. Mahjoub1, N. Ben Romdhan1

  • Abstract Number: PB0282

    Hematologic Parameters of Ghanaian COVID-19 Patients at Diagnosis

    D. Fiawoo1, B. Opoku-Asare2, E. Olayemi1

  • Abstract Number: PB0350

    Hemolysis Interference in the Anti-Xa Heparin Activity Assay

    K. Ruby1, L. Salvatore1, R. Lomachinsky1, D. Ornstein1,2, J. Khan1

  • Abstract Number: PB1044

    Hemophagocytic Lymphohistiocytosis Complicating Systemic Diseases

    I. Chabchoub1, R. Ben Salah1, F. Abida2, F. Frikha1, M. Chaari2, Z. Bahloul1

  • Abstract Number: PB0507

    Hemophilia A Patients with Factor Ⅷ Inhibitor Feature Reduced Levels of CD4+CD25+CD127- Treg Cells and Plasma IL-35

    Z.Y. Yan1, Z. Yan1, H. He1, Y. Xie1, L. Wang1, W. Wu1, S. Chen1, Y. Yan1, J. Yang1

  • Abstract Number: PB0635

    Hemophilia and Concussion Outcome Study (HeCos): Neurological Status of Children with Hemophilia – Prevalence and Relevance of Mild Traumatic Brain Injury

    A. Berghuber1, C. Bidlingmaier1, M. Marx1, S. Lardschneider1, L. Wiederer1, M. Olivieri1, S. Juranek1, S. von Mackensen2, K. Kurnik1, M. Bonfert1

  • Abstract Number: PB0523

    Hemophilia Treatment in 2021: Choosing the ‘Optimal’ Treatment Using an Integrative, Patient-orientated Approach to Shared Decision-making between Patients and Clinicians

    C. Hermans1, G. Benson2, G. Dolan3, H. Eichler4, V. Jiménez-Yuste5, C. Königs6, S. Lobet1, M.E. Mancuso7, D. Noone8, D. Pollard9, S. Zupančić Šalek10

  • Abstract Number: PB0209

    Hemoreologic Disorders in COVID-19 Patients

    O. Kostina1, E. Galova1, A. Popovicheva1, L. Sosnina1, M. Presnyakova1

  • Abstract Number: PB0710

    Hemorrhagic Adventitious Bursitis of the Foot in a Patient with Congenital Type 3 von Willebrand Disease

    R. Gualtierotti1, S.M. Stella2, E. Biguzzi3, S.M. Siboni3, S. Arcudi1, L.P. Solimeno3, F. Payvandi1

  • Abstract Number: PB0900

    Hemorrhagic Phenotype in Pediatric Patients with Glanzmann Thrombasthenia (GT)

    D. Fedorova1, E. Seregina1, A. Poletaev1, A. Pshonkin1, P. Zharkov1

  • Abstract Number: PB0055

    HemosIL Liquid Anti-Xa Apixaban Measurement in Patients with High Risk of Major Bleeding

    J. Hammelburger1, Z. Cao1, C. Kung1

  • Abstract Number: PB0162

    Hemostasiological Blood Properties in Patients with COVID-19 Associated Viral Pneumonia

    M. Presnyakova1, E. Galova1, O. Kostina1

  • Abstract Number: PB0272

    Hemostasis Abnormalities in Post-COVID-19 Syndrome

    M. Noniashvili1, T. Saralidze1, T. Svanidze1, T. Kandashvili1, I. Mamatsashvili1

  • Abstract Number: PB0266

    Hemostasis Disorder in COVID-19 Patients: Disseminated Intravascular Clotting (DIC)?

    E. Klychnikova1, K. Popugaev1, E. Tazina1, S. Petrikov1, S. Badygov1, A. Bulanov1

  • Abstract Number: PB0239

    Hemostastatic Alterations with Disease Severity in the Early Symptomatic Phase of COVID-19

    S. Huber1, S. Montalvão1, S. Martins1, L. da Silva1, C. Bacchin1, N. Santos1, T. Diaz2, C. Wroclawsk3, C. Filho3, E. de Paula1, J. Annichino-Bizzacchi1

  • Abstract Number: PB0325

    Hemostatic and Thrombogenic Properties of Lyophilized Human Platelets

    H. Zhou1, A. Lee2, K. Moskowitz2, T. Diacovo1

  • Abstract Number: PO121

    Hemostatic Defects Associated with IgA Monoclonal Gammopathy

    M.C. Shen1,2, C.-W. Huang1, G.-M. Lai1, Y.-H. Shih1, C.-Y.L. Lin1, H.-Y. Lin1, S.-F. Kuo1, J.-S. Lin1

  • Abstract Number: PB0181

    Hemostatic Disorders Are Associated with the Course and Outcomes of COVID-19

    R.I. Litvinov1,2, N.G. Evtugina2, A.D. Peshkova2, S.I. Safiullina2,3, I.A. Andrianova2, R.R. Khismatullin2, S.S. Sannikova4, S.M. Abdullaeva2, A.I. Khabirova2, J.W. Weisel1

  • Abstract Number: PB0451

    Hemostatic Effect of Tranexamic Acid Combined with Emicizumab in Prophylactic Setting in Severe Hemophilia A: A Preclinical Study

    Y. Dargaud1, N. Enjolras2, M. Janbain3, R. Bolbos4, M. Brevet5, J.-C. Bordet2

  • Abstract Number: PB0435

    Hemostatic Evaluation by Global Coagulation Assays in Patients with Acquired Hemophilia A: Analysis of Multi Centers in Japan

    M. Takeyama1, S. Furukawa1,2, K. Yada1,3, K. Ogiwara1, T. Onishi1, M. Shima1, K. Nogami1

  • Abstract Number: PB0758

    Hemostatic Evaluation by Thromboelastography in Patients from a Peruvian Oncologic Center

    L.F. Motta Rosada1, R.M. Rodriguez Torres1, N.V. Herrera Valverde2

  • Abstract Number: PO123

    Hemostatic Function in Patients with Factor XI Deficiency

    L. Montero Martín1, N. Butta2, M.C Vázquez Rodriguez1, E. Monzón Manzano3, P. Auña3, E.G. Arias Salgado3

  • Abstract Number: PB1142

    Hemostatic Genetic Risk Factors of Aseptic Cerebral Venous Thrombosis

    K. Stepanchenko1, O. Tsymbal1, A. Zhydkova1

  • Abstract Number: OC 50.2

    Hemostatic Profile of COVID-19 Convalescent Plasma (CCP) Donors from Bergamo Area

    C.J. Tartari1, G. Milani1, F. Salvetti1, M. Marchetti1, L. Russo1, A. Vignoli1, M. Vitali1, L. Barcella1, M. Cefis1, P. Gomez-Rosas1, F. Schieppati1, G. Ravasio1, L. Castellani1, G. Marchesi1, E. Sanga1, D. Romeo1, A. Falanga1,2

  • Abstract Number: OC 67.1

    Hemostatic Response is Maintained for up to 5 Years Following Treatment with Valoctocogene Roxaparvovec, an AAV5-hFVIII-SQ Gene Therapy for Severe Hemophilia A

    KJ. Pasi1, S. Rangarajan2, T.M Robinson3, W. Lester4, E. Symington5, B. Madan6, M. Laffan7, M. Li3, B. Kim3, G.F Pierce8, W.Y. Wong3

  • Abstract Number: OC 59.3

    Hemostatic Treatment of Patients with Rare Bleeding Disorders in the Netherlands: Real-life Data from the RBiN Study

    D. Maas1,2, J. Saes1,2, K. Meijer3, M. Cnossen4, R. Schutgens5, M. Peters6, L. Nieuwenhuizen2,7, P. den Exter8, I. Kruis9, W. van Heerde1,2,10, S. Schols1,2

  • Abstract Number: PB0343

    Heparin Interference of the Thrombin Generation Assay Can Be Eliminated by Heparinase Treatment

    A. Weber1, M. LLusa2, H. Gritsch1, N.B Binder2

  • Abstract Number: OC 27.3

    Heparin Modulates FV Procofactor Regulatory Region and Susceptibility to APC

    F. Ayombil1, R.M. Camire2

  • Abstract Number: PB1275

    Heparin Therapeutic Range for Five aPTT Reagents in Plasma and One Point of Care

    E. Cortina-de la Rosa1, K.G. Cortés-Cortés1, M.O. Romero-Arroyo1, F.A. Grimaldo-Gómez1, M.M. Salcedo-Hernández1, Á.A. Arrieta-Alvarado1, A. Ramírez-Hernández1, S. Vázquez-Olvera1, R. Izaguirre-Ávila1

  • Abstract Number: PB0127

    Heparin-binding Copolymer Completely Reverses the Anticoagulant Effect of Subcutaneously Administered Enoxaparin in Mice

    J. Swieton1, B. Kalaska1, J. Miklosz1, S.-I. Yusa2, K. Szczubialka3, D. Pawlak1, A. Mogielnicki1

  • Abstract Number: PB0259

    Heparin-induced Thrombocytopenia (HIT) during Extracorporeal Membrane Oxygenation (ECMO) in COVID-19: A Case Report

    G.A. Altamirano-Solorzano1, E. Cortina-de la Rosa1, F.A. Grimaldo-Gomez1, V.M. Anguiano-Alvarez1, K.G. Cortes-Cortes1, M. Porres-Aguilar2,3, G. Rojas-Velasco1, R. Izaguirre-Avila1

  • Abstract Number: PB0702

    Hereditary Haemorrhagic Telangiectasia (HHT) or Rendu-Osler Weber Disease as an Important Rare Haemorrhagic Disorder in Costa Rica: A Report of Costa Rica

    L. Salazar-Sanchez1, K. Leiva-Gabriel1, B.I. Hernandez-Salazar1, C. Salazar-Chacon2

  • Abstract Number: PB1315

    Hereditary Thrombophilia in Macedonian Women with in vitro Fertilization Failure

    E. Petkovikj1, R. Grubovic Rastvorceva1, T. Makarovska Bojadzieva1, E. Velkova1, V. Dejanova1, E. Ristovska1, S. Useini1

  • Abstract Number: PB1164

    Heterozygosity for factor V Leiden with a Catastrophic Presentation

    R. Pombal1, L. Vieira1, S. Lopes1, R. Neto1, H. Gomes1, M. Figueiredo1

  • Abstract Number: PO154

    Heterozygous FV Leiden Mutation Associated with Multiple Cerebral Venous Thrombosis in Childhood. A Case Report

    Y. Larfi1, N. Ait Hamouda1, M. Agha1, D. Dahlouk1

  • Abstract Number: PB0001

    High Concentration of Symmetric Dimethylarginine is Associated with Low Platelet Reactivity and Increased Bleeding Risk in Patients with Acute Coronary Syndrome

    C. Eyileten1, J. Jarosz-Popek1,2, D. Jakubik1, A. Gąsecka3, M. Wolska1, A. Fitas1, P. Czajka1, A. Nowak1, M. Ufnal4, M. Postuła1, J.M. Siller-Matuła5,1

  • Abstract Number: LPB0115

    High Impact and Severe Outcomes of Intracranial Hemorrhage (ICH) in an Italian Population of Adult Mild Hemophiliac Patients: Data from the EMO.REC Registry

    E. Zanon1, S. Pasca1, F. Demartis2, A. Tagliaferri3, C. Santoro4, I. Cantori5, A.C. Molinari6, C. Biasioli7, A. Coppola3, G. Castaman2, S. Linari2, M. Luciani8, G. Sottilotta9, I. Ricca10, B. Pollio10, A. Borchiellini11, A. Tosetto12, P. Simioni1, F. Peyvandi13

  • Abstract Number: PB0174

    High Incidence and Early Presence of arterial thrombotic events in a COVID-19 hospitalized population: an overlooked problem?

    M. de Oliveira1, F. Cubal2, J. Oliveira3, E. Cruz1, M. Coutinho1, M. Pereira1, R. Matos1, N. Pinho1, L. Moreira1, N. Seidi1, S. Morais1

  • Abstract Number: PB0936

    High Plasma von Willebrand Factor Level is Associated with Increased Risk of upper Gastrointestinal Bleeding in Patients with Chronic Coronary Syndromes Receiving Long-term Antiplatelet Therapy

    V. Korobkova1, A. Komarov1, O. Shakhmatova1, A. Dobrovolsky1, E. Novikova1, E. Guskova1, E. Titaeva1, E. Yarovaya2, A. Shuleshova1, E. Panchenko1

  • Abstract Number: PB0030

    High Shear Conditions Takes Place at the Edge of the Wound after Human and Mouse Vessel Injury

    A. Yakusheva1,2,3, K. Butov2,3,4, F. Ataullakhanov2,3,5, C. Gachet1, M. Panteleev2,3,5, P. Mangin1

  • Abstract Number: OC 04.1

    High Throughput Sequencing for the Molecular Diagnosis of Inherited Platelet Disorders in Spain. Experience of the GEAPC Group

    J.M. Bastida1,2,3,4, M.L Lozano5,6, R. Benito2,3,7, A. Rodríguez-Alén8, N. Butta9, N. Fernández-Mosteirin:10, T. Sevivas11, A. Marco-Rico12, N. Revilla13, J. Huertas-Aragonés14, A. Marin-Quílez2,3,4, V. Palma-Barqueros5,6,4, S. Marcellini15, P. Velasco16, M.d.M. Nieto17, C. Sierra-Aisa18, M.N. Alonso19, M.F López-Fernández20, J.R. González-Porras:1,2,3, J. Rivera5,6,4, GEAPC Study Group

  • Abstract Number: OC 04.2

    High-sensitivity Platelet Proteomics Maps the Response to Different Levels of Thrombin

    C. Houlahan1, Y. Kong2,3, M. Cielesh4, M. William1,5, P. Coleman6,1, M. Larance4, F. Passam2,3

  • Abstract Number: PB0688

    High-throughput Screening for Pharmacological Enhancers of Mutated Factor VII Activity

    E. Andersen1,2, M.C. Mowinckel1,2, B. Stavik1,2, P.M. Sandset1,2,3, M.E. Chollet1,2

  • Abstract Number: PB0970

    Highly Reactive Juvenile Platelets Express Higher Levels of GPVI in a Size-related Manner

    A. Veninga1, S. Handtke2, B.M.E. Tullemans1, S.L.N. Brouns1, A. Greinacher2, J.W.M. Heemskerk1, P.E.J. van der Meijden1,3, T. Thiele2

  • Abstract Number: OC 54.3

    Histidine-rich Glycoprotein Attenuates Catheter Thrombosis in Rabbits

    R.A. Malik1,2, P. Liao1,2, J. Zhou1,2, J.C. Fredenburgh1,2, R.H. Hussain1,2, A. Revenko3, J.I. Weitz1,2

  • Abstract Number: LPB0050

    History of Cancer is Associated with Increased Platelet Activity and Atherothrombosis in Patients with Peripheral Artery Disease

    L. Cofer1, T. Barrett2, Y. Xia3, E. Luttrell-Williams4, K. Myndzar4, K.-K. Wong5,6, D. Wise7, J. Berger2,8

  • Abstract Number: PB0842

    HIV is Not the Trigger for HIV-associated TTP

    M. Meiring1, M. Khemisi2.

  • Abstract Number: PB0113

    HIV-1 and SARS-CoV-2 Both Cause Protein S, but through Different Mechanisms

    M.M. Sim1, H.R. Alfar1, M. Hollifield1, D.W. Chung2, X. Fu2, M. Banerjee1, X. Li1, A.C. Thornton1, J.Z. Porterfield1, J.L. Sturgill1, G.A. Sievert1, M. Barton-Baxter1, K.S. Campbell1, J.G. Woodward1, J.A. Lopez2, S.W. Whiteheart1, B.A. Garvy1, J.P. Wood1

  • Abstract Number: PO118

    Homocysteine Exchange in Athletes in the Arctic Region

    N. Vorobyeva1,2, N. Malyshkina2

  • Abstract Number: PB1285

    Hormonal Contraception (HC) and Thrombosis: Identifying the Gaps in Knowledge among Young Woman

    Y. Deng1,2, S. Tierney2, A. Geauvreau1, M. Velez3, M. Othman1,2

  • Abstract Number: PB1202

    How Common Are Uterine Venous Plexus Thrombi in Women Attending the Gynaecology Clinic?

    T. Amin1, H. Cohen2, M. Wong2, D. Jurkovic2

  • Abstract Number: PO170

    How to Use the Data about Risk Factors for Thrombosis in Practice

    L. Stanciakova1, K. Chromekova1, K. Vajdova1, M. Dobrotova1, P. Holly1, M. Brunclikova1, T. Bolek2, M. Samos2, P. Kubisz1, J. Stasko1

  • Abstract Number: LPB0026

    How to Use Thrombolytic Agents in the Treatment of Neonatal Thrombosis: A Systematic Review

    R. Leong1, J. Patel2, N. Samji3, B. Paes3,4, A.KC Chan4, J.-A. Petropoulos5, M.D Bhatt4

  • Abstract Number: PB0698

    Human Fibrinogen Concentrate for Bleeding Prophylaxis During Surgery in Adult, Adolescent and Pediatric Patients with Congenital Fibrinogen Deficiency: Results from the FORMA-02 and FORMA-04 Clinical Trials

    C. Djambas-Khayat1, S. Lohade2, F. D'Souza3, L. Shamanur4, O. Zekavat5, I. Kruzhkova6, B. Schwartz7, C. Solomon6

  • Abstract Number: PB0765

    Human Myeloperoxidase Enhances Thrombin Induced Phosphatidylserine Exposure in Human Platelets through Tyrosine Kinase/Calcium/Potassium Channels-mediated Pathway

    A Kokhan1, F Balabin2,3, I Gorudko1, A Sokolov4,5, A Sveshnikova2,3,6, E Shamova1

  • Abstract Number: PB0206

    Hypercoagulability Detected by Seer Sonorheometry in Covid-19 Patients at Hospital Admission

    F.J. López Jaime1, S. Martín-Téllez1, A. Doblas-Márquez1, I. Márquez-Gómez2, J. Alemany1, M. Pérez-Raya1, A.M. Mena-Santano1, D.F. Muñoz-López1, M.I. Muñoz-Pérez1, I. Fernández-Bello3, A. Montaño1

  • Abstract Number: PB0226

    Hypercoagulable Rotational Thromboelastometry NaHEPTEM Profile is Related to Mechanical Ventilation Requirement among Critically ill COVID-19 Patients

    I. Carboni Bisso1, I. Huespe2,3, M. Las Heras1, E. Prado1, M. Garbarini4, M.S. López5,6, L. Barrera5,6, J. Sinner1, M. Martinuzzo5,6

  • Abstract Number: PB0215

    Hypercoagulation by Rotational Thromboelastometry (ROTEM) Predicts Mortality in COVID-19: A Prospective Observational Study

    L. Almskog1, A. Wikman2, J. Svensson3, C.M. Wahlgren1, M. Wanecek4, M. Bottai5, J. van der Linden1, A. Ågren1,6

  • Abstract Number: PB1205

    Hypoalbuminemia, Not Proteinuria, Is Associated with Increased Venous Thromboembolism Risk among Primary Glomerulonephritis Patients with Nephrotic Syndrome: A Meta-analysis of Cohort Studies

    B.P. Putra1, F.N. Putra2

Jump to:  View All • a b c d e f g [h] i j k l m n o p q r s t u v w x y z
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2022 John Wiley & Sons, Inc. All Rights Reserved.
Wiley